The present invention includes methods of preventing a ceramide-sensitive cancer comprising: identifying a subject that has been treated for the ceramide-sensitive cancer and providing to the subject an effective amount of a combination of a sphingosine kinase inhibitor and a ceramide inducing agent or a ceramide analog in an amount sufficient to prevent or reduce the recurrence of the ceramide-sensitive cancer.